Presented by Slim Fourati
REF: Fourati S. et al. (2018). Nat Commun 9(1):4418.
DOI: 10.1038/s41467-018-06735-8
A crowdsourced analysis to identify ab initio molecular signatures predictive of susceptibility to viral infection
Acute Upper Respiratory Tract Infection
Why aren’t we sick all the time?
Host factors
Gene expression signatures predict which patients get sick starting 36 hours post-viral exposure
REF: Zaas AK et al. (2009) Cell Host Microbe 6(3):207-17. Fig. 5
REF: Huang Y et al. (2011) PLoS Genet 7(8):e1002234. Fig. 4
Can we identify early stage predictors of viral infection?
Human Viral Challenge Data
🤒
🤒
-24
0 12 24 36 48 60 72 96 120
😊
😊
😊
🤒
Transcriptomics
Respiratory Viral DREAM challenge workflow
*data includes previously published (3/4, accession number not provided to participants) and unpublished data (1/4)
Challenge data and outcomes by viruses
Longitudinal transcriptomic data
Static endpoints
*log symptom score: maximum symptom score over 10 days period after exposure
Log symptom score
Subchallenge 2: symptom onset
Subchallenge 3: log-symptom score
Subchallenge 1: viral shedding
What drive accuracy of models?
Features selected by predictive models
Heme metabolism and Severe COVID-19
Ref: Maestro S et al. (2021) Biomed Phamacother
The Arg134 residue in ORF3a may interact with the iron in heme and then kick off the iron from the heme through a redox reaction, generating dysfunctional hemoglobin
The dysfunction of hemoglobin leads to an altered cascade of several biochemical events, which includes low-level oxygenation, elevated free iron level, and down-regulation of heme oxygenase-1 (HO-1)
heme catabolite CO also suppresses the NF-κB signaling pathway and thereby impedes replication of virus
REF: Maiti BK (2020) ACS Pharmacol. Transl. Sci. 3, 1032–1034
Acknowledgments
Funding:
(Data generation) DARPA, ARO Proposal number 67037-L-DRP
(SF) NIAID U19 AI135972-03; PO: Reed S. Schabman